A consortium of scientists and transplant clinicians led by Shahin Rafii and Joseph Scandura has been awarded a $15.7 million, four-year research grant. Read more
Laurie H. Glimcher provides commentary on new data reporting therapies that involve using CAR T cells, white blood cells taken from the body and genetically modified to have the cancer-spotting traits of antibodies. Read more
Meyer Cancer Center member John Lis, the Barbara McClintock Professor of Molecular Biology and Genetics based in Ithaca, was among three Cornell faculty members recently elected to the American Academy of Arts and Sciences. Read more
Research by David Lyden into the immune suppression function of the Inhibitor of Differentiation 1 gene may lead to new therapies for melanoma and other advanced-stage cancers. Read more
Esophageal cancer patients who survived five years after surgery were likely to survive longer despite recurrence risk, according to a new study by Brendon Stiles, M.D. Read more